Novella Clinical (Quintiles) specializes in providing comprehensive clinical development solutions tailored specifically for biotech companies. Their approach emphasizes the importance of dedicated teams that support clients from early-stage strategy development through to trial execution and regulatory approval. With a strong foundation in therapeutic expertise, particularly in oncology, cell and gene therapies, and other specialized areas, Novella aims to simplify the complexities of clinical trials. They leverage advanced data analytics and innovative trial designs, including decentralized and hybrid models, to enhance patient recruitment and streamline processes, ultimately accelerating the delivery of breakthrough treatments to patients.

The company boasts extensive experience in managing both early and late-phase clinical trials, with a proven track record of over 500 studies conducted in the past five years across more than 50 countries. Their team includes board-certified oncologists and hematologists, ensuring that clients benefit from high-level scientific and operational expertise. Novella's commitment to patient-centric trial strategies and their ability to adapt to the unique challenges of each therapeutic area position them as a vital partner for biotech innovators seeking to navigate the complexities of drug development and bring new therapies to market efficiently.

United States

Supporting biotech companies from innovation to impact. Specialized clinical development solutions with dedicated teams. IQVIA Biotech is a CRO strategic problem-solver with therapeutic expertise.

Novella Clinical (Quintiles)

Company Details